Exploring Two Treatments for Misophonia
Exploring Two CBT-based Treatments as Interventions for Emotion Dysregulation in Misophonia
1 other identifier
interventional
12
1 country
1
Brief Summary
While the investigators continue to work on better understanding Misophonia, it is also important to identify treatments that can help people who are currently suffering. Further, it is important that the treatments provided are acceptable to the people who receive them. In this study, participants will complete one of two treatments the investigators believe can help manage symptoms of Misophonia: The Unified Protocol or process-based therapy. Both treatments will use evidence-based psychological principles (e.g., managing attention or behavior) in a flexible manner and will focus on developing skills to help reduce the distress and impairment associated with Misophonia. The aims of this study are (1) to explore the acceptability and feasibility of these treatments for individuals who experience Misophonia and (2) to examine whether these treatments help reduce symptoms associated with Misophonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2019
CompletedFirst Posted
Study publicly available on registry
December 13, 2019
CompletedStudy Start
First participant enrolled
September 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2022
CompletedNovember 25, 2022
December 1, 2021
2.2 years
December 12, 2019
November 22, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Number of patients that are satisfied with treatment as measured by the credibility and expectancy questionnaire (CEQ)
The CEQ is a 6-item measure that asks patients about their perceptions of treatment.
up to 20 weeks
Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable)
This form has two questions that assess how satisfied patients were with treatment and how acceptable treatment was to them. The remaining three items are open ended questions that allow patients to provide narrative feedback about their experience in treatment.
up to 20 weeks
Secondary Outcomes (5)
Change in misophonia symptoms as assessed by the Misophonia Questionnaire
assessed weekly, up to 24 weeks
Change in anxiety as measured by the Overall Anxiety Severity and Impairment Scale
assessed weekly, up to 24 weeks
Change in depression as measured by the Overall Depression Severity and Impairment Scale
assessed weekly, up to 24 weeks
Change in anger as measured by the Clinical Anger Scale
assessed weekly, up to 24 weeks
Number of patients who use the skills taught in treatment as measured by the Skill Use Questionnaire
assessed weekly, up to 24 weeks
Study Arms (4)
Unified Protocol, 2 week baseline
EXPERIMENTALParticipants in this arm will complete two weeks of baseline assessment (during which they will complete questionnaires but not start treatment) and then receive 16 sessions of the Unified Protocol (UP). The UP is an emotion-focused treatment designed to teach participants skills to help manage difficult experiences.
Unified Protocol, 4 week baseline
EXPERIMENTALParticipants in this arm will complete four weeks of baseline assessment (during which they will complete questionnaires but not start treatment) and then receive 16 sessions of the Unified Protocol (UP). The UP is an emotion-focused treatment designed to teach participants skills to help manage difficult experiences.
Process-based treatment, 2 week baseline
EXPERIMENTALParticipants in this arm will complete two weeks of baseline assessment (during which they will complete questionnaires but not start treatment) and then receive 16 sessions of the process-based therapy. Process-based therapy is a flexible therapy designed to teach skills that help people manage difficult experiences. Patient and therapist work together to determine which skills will be utilized.
Process-based treatment, 4 week baseline
EXPERIMENTALParticipants in this arm will complete four weeks of baseline assessment (during which they will complete questionnaires but not start treatment) and then receive 16 sessions of the process-based therapy. Process-based therapy is a flexible therapy designed to teach skills that help people manage difficult experiences. Patient and therapist work together to determine which skills will be utilized.
Interventions
Please see arm/group descriptions
Please see arm/group descriptions
Eligibility Criteria
You may qualify if:
- Over age 18
- Able to read English
- Meet criteria for interfering symptoms of misophonia
- Live in North Carolina
You may not qualify if:
- Under age 18
- Current mania
- Current psychotic disorder
- Current anorexia
- Presents with a condition that requires immediate prioritization in treatment (e.g., suicide planning or intent)
- Has received any treatment specifically for misophonia in the past year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27701, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Zachary Rosenthal, Ph.D.
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2019
First Posted
December 13, 2019
Study Start
September 11, 2020
Primary Completion
November 21, 2022
Study Completion
November 21, 2022
Last Updated
November 25, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share